Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC-T vs EC-TCb in Triple-Negative Breast Cancer
NCT02455141Phase 3Active, not recruiting
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Mar 2016
- Primary completion
- Mar 2027
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin in triple-negative breast cancer (TNBC), sponsored by Shanghai Jiao Tong University School of Medicine. Started Mar 2016; status: active, not recruiting.
02
Drugs
carboplatin
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT02455141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02455141.